These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 34783962)

  • 21. Imbalances in circulating angiogenic factors in the pathophysiology of preeclampsia and related disorders.
    Rana S; Burke SD; Karumanchi SA
    Am J Obstet Gynecol; 2022 Feb; 226(2S):S1019-S1034. PubMed ID: 33096092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microvascular endothelial cells from preeclamptic women exhibit altered expression of angiogenic and vasopressor factors.
    Lee DK; Nevo O
    Am J Physiol Heart Circ Physiol; 2016 Jun; 310(11):H1834-41. PubMed ID: 27199113
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiogenic and vasoactive proteins in the maternal-fetal interface in healthy pregnancies and preeclampsia.
    Westerberg AC; Degnes ML; Andresen IJ; Roland MCP; Michelsen TM
    Am J Obstet Gynecol; 2024 Mar; ():. PubMed ID: 38494070
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating concentrations of soluble endoglin (CD105) in fetal and maternal serum and in amniotic fluid in preeclampsia.
    Staff AC; Braekke K; Johnsen GM; Karumanchi SA; Harsem NK
    Am J Obstet Gynecol; 2007 Aug; 197(2):176.e1-6. PubMed ID: 17689641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MMP-14 aggravates onset of severe preeclampsia by mediating soluble endoglin release.
    Zhang XH; Zhang HY; Lu S; Jiang LL; Wu J; Yang YL; Zhang SA
    Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1209-1215. PubMed ID: 29565476
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exosomes From Women With Preeclampsia Induced Vascular Dysfunction by Delivering sFlt (Soluble Fms-Like Tyrosine Kinase)-1 and sEng (Soluble Endoglin) to Endothelial Cells.
    Chang X; Yao J; He Q; Liu M; Duan T; Wang K
    Hypertension; 2018 Dec; 72(6):1381-1390. PubMed ID: 30571229
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Single Sphingomyelin Species Promotes Exosomal Release of Endoglin into the Maternal Circulation in Preeclampsia.
    Ermini L; Ausman J; Melland-Smith M; Yeganeh B; Rolfo A; Litvack ML; Todros T; Letarte M; Post M; Caniggia I
    Sci Rep; 2017 Sep; 7(1):12172. PubMed ID: 28939895
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between endoglin/transforming growth factor beta receptors 1, 2 gene polymorphisms and the level of soluble endoglin with preeclampsia in Egyptian women.
    ElMonier AA; El-Boghdady NA; Abdelaziz MA; Shaheen AA
    Arch Biochem Biophys; 2019 Feb; 662():7-14. PubMed ID: 30496724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate.
    Romero R; Nien JK; Espinoza J; Todem D; Fu W; Chung H; Kusanovic JP; Gotsch F; Erez O; Mazaki-Tovi S; Gomez R; Edwin S; Chaiworapongsa T; Levine RJ; Karumanchi SA
    J Matern Fetal Neonatal Med; 2008 Jan; 21(1):9-23. PubMed ID: 18175241
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of soluble endoglin in BMP9 signaling.
    Lawera A; Tong Z; Thorikay M; Redgrave RE; Cai J; van Dinther M; Morrell NW; Afink GB; Charnock-Jones DS; Arthur HM; Ten Dijke P; Li W
    Proc Natl Acad Sci U S A; 2019 Sep; 116(36):17800-17808. PubMed ID: 31431534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activating Transcription Factor 3 Is Reduced in Preeclamptic Placentas and Negatively Regulates sFlt-1 (Soluble fms-Like Tyrosine Kinase 1), Soluble Endoglin, and Proinflammatory Cytokines in Placenta.
    Kaitu'u-Lino TJ; Brownfoot FC; Hastie R; Chand A; Cannon P; Deo M; Tuohey L; Whitehead C; Hannan NJ; Tong S
    Hypertension; 2017 Nov; 70(5):1014-1024. PubMed ID: 28947613
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1.
    Cudmore M; Ahmad S; Al-Ani B; Fujisawa T; Coxall H; Chudasama K; Devey LR; Wigmore SJ; Abbas A; Hewett PW; Ahmed A
    Circulation; 2007 Apr; 115(13):1789-97. PubMed ID: 17389265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of Pravastatin on Human Placenta, Endothelium, and Women With Severe Preeclampsia.
    Brownfoot FC; Tong S; Hannan NJ; Binder NK; Walker SP; Cannon P; Hastie R; Onda K; Kaitu'u-Lino TJ
    Hypertension; 2015 Sep; 66(3):687-97; discussion 445. PubMed ID: 26222708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Down-regulated miR-149-5p contributes to preeclampsia via modulating endoglin expression.
    Xiaobo 赵肖波 Z; Qizhi H; Zhiping W; Tao D
    Pregnancy Hypertens; 2019 Jan; 15():201-208. PubMed ID: 30713088
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiple Soluble TGF-β Receptors in Addition to Soluble Endoglin Are Elevated in Preeclamptic Serum and They Synergistically Inhibit TGF-β Signaling.
    Wang Y; Chen Q; Zhao M; Walton K; Harrison C; Nie G
    J Clin Endocrinol Metab; 2017 Aug; 102(8):3065-3074. PubMed ID: 28633389
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Soluble endoglin concentration in maternal blood as a diagnostic biomarker of preeclampsia: A systematic review and meta-analysis.
    Margioula-Siarkou G; Margioula-Siarkou C; Petousis S; Margaritis K; Alexandratou M; Dinas K; Sotiriadis A; Mavromatidis G
    Eur J Obstet Gynecol Reprod Biol; 2021 Mar; 258():366-381. PubMed ID: 33529972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A longitudinal analysis of angiotensin II type 1 receptor antibody and angiogenic markers in pregnancy.
    Aggarwal S; Sunderland N; Thornton C; Xu B; Hennessy A; Makris A
    Am J Obstet Gynecol; 2017 Feb; 216(2):170.e1-170.e8. PubMed ID: 27793555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TGFβ signalling: a nexus between inflammation, placental health and preeclampsia throughout pregnancy.
    Horvat Mercnik M; Schliefsteiner C; Sanchez-Duffhues G; Wadsack C
    Hum Reprod Update; 2024 Jul; 30(4):442-471. PubMed ID: 38519450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Racial-ethnic differences in midtrimester maternal serum levels of angiogenic and antiangiogenic factors.
    Yang J; Pearl M; DeLorenze GN; Romero R; Dong Z; Jelliffe-Pawlowski L; Currier R; Flessel M; Kharrazi M
    Am J Obstet Gynecol; 2016 Sep; 215(3):359.e1-9. PubMed ID: 27073062
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension.
    Noori M; Donald AE; Angelakopoulou A; Hingorani AD; Williams DJ
    Circulation; 2010 Aug; 122(5):478-87. PubMed ID: 20644016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.